NCT05184556

Brief Summary

This randomized, controlled effectiveness trial will assess outcomes, implementation, and mechanisms of two psychological treatments for adolescent anorexia nervosa (AN) delivered in the home setting, in the context of community-based mental health. Adolescents with AN-spectrum disorders (n=50) and their caregivers will be randomly assigned to either family-based treatment or integrated family therapy delivered in the home. Caregivers and adolescents will provide data on weight, eating, and putative treatment mechanisms, including caregiver self-efficacy, adolescent distress, and generalizability of treatment skills. Treatment feasibility, acceptability, and appropriateness will be measured among providers and participating families. The proposed study has clear potential to advance scientific and clinical understanding of the real-world effectiveness of psychological treatments for AN, including whether adapting them for the home setting may improve accessibility and effects on treatment outcome

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
77

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 11, 2022

Completed
7 months until next milestone

Study Start

First participant enrolled

August 1, 2022

Completed
3.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2026

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
Last Updated

April 14, 2026

Status Verified

April 1, 2026

Enrollment Period

3.7 years

First QC Date

December 1, 2021

Last Update Submit

April 8, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Body mass index percentile

    Adolescents will have their height and weight measured to calculate BMI percentile using CDC growth charts and accompanying procedures.

    Up to 32-weeks post randomization

  • Eating Disorder Examination

    The Eating Disorder Examination will be used to diagnose anorexia nervosa, and assess eating disorder behaviors, attitudes, and cognitions. Items are scored from 0-7 and averaged to create subscales reflecting restraint, eating concerns, shape concerns, weight concerns, and global eating-related psychopathology. Higher scores indicate more severe eating disorder symptoms.

    Up to 32-weeks post randomization

Secondary Outcomes (10)

  • Abbreviated Acceptability Rating Profile

    Up to 32-weeks post randomization

  • Therapy Suitability and Patient Expectancy

    Up to 32-weeks post randomization

  • Acceptability, Appropriateness, and Feasibility of Intervention Measure

    Up to 3 years

  • Client Satisfaction Questionnaire

    Up to 32-weeks post randomization

  • Multi-theoretical List of Therapeutic Interventions

    Up to 32-weeks post randomization

  • +5 more secondary outcomes

Other Outcomes (12)

  • Subjective Units of Distress Scale

    Up to 32-weeks post randomization

  • Parent vs. Anorexia Scale

    Up to 32 weeks post-randomization

  • General Self Efficacy Scale

    Up to 32 weeks post-randomization

  • +9 more other outcomes

Study Arms (2)

Family-based treatment

EXPERIMENTAL

Families will complete 2-6 hours of therapy per week for 10 - 32 weeks, on average, determined by clinical need in conjunction with insurance specifications related to coverage of home-based care

Behavioral: Family-based treatment (FBT)

Integrative family therapy

ACTIVE COMPARATOR

Families will complete 2-6 hours of therapy per week for 10 - 32 weeks, on average, determined by clinical need in conjunction with insurance specifications related to coverage of home-based care

Behavioral: Integrative family therapy

Interventions

FBT is a structured behavioral treatment focused on empowering caregivers to take charge of the adolescent's eating behavior and return him/her to a normative weight and developmental trajectory. FBT involves three consecutive phases: 1) caregivers are fully in control of the adolescent's eating; 2) control of eating is gradually returned to the adolescent; and 3) developmental issues are explored. In the current study, FBT is adapted for delivery in the home setting in the following ways: intensified dose of treatment (2-6 hours of therapy per week over 10 - 32 weeks); use of clinician as an additional support to the family; multiple family meals in the home and community; sociocultural tailoring; and inclusion of supplemental individual work with the adolescent to improve emotion regulation/distress tolerance.

Family-based treatment

The integrated family therapy approach includes psychoeducation, supportive family therapy, and elements of cognitive-behavioral interventions. Families may be referred for additional nutritional counseling and prescribed a meal plan as indicated. Typical strategies include educating families on the presentation and prognosis of adolescent AN; identifying dysfunctional family structures/alliances and communication patterns; using reflective listening to engage and validate family members; challenging maladaptive beliefs about eating and weight; and supporting families in developing strategies for management of both general and eating disorder-specific distress. Treatment is generally non-directive.

Integrative family therapy

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Meets criteria for AN or atypical AN according to DSM-5 diagnostic criteria.
  • Currently living at home with caregivers who are willing to engage in family treatment.
  • Medically stable for outpatient treatment according to the recommended thresholds of the American Academy of Pediatrics and the Society of Adolescent Medicine (e.g., ≥75% of expected body weight, heartrate ≥50 beats per minute) and receiving medical monitoring from a clinician throughout treatment.
  • If on psychotropic medication, meets all eligibility criteria while on stable dose of psychotropic medication for a co-morbid condition.
  • Available for follow-up.

You may not qualify if:

  • Associated physical illness that necessitates hospitalization.
  • Psychotic illness/other mental illness requiring hospitalization.
  • Current dependence on drugs or alcohol.
  • Physical conditions (e.g. diabetes mellitus, pregnancy) known to influence eating or weight.
  • Concurrent involvement in other psychological treatment for an eating disorder.
  • Developmental delay that would preclude participation in the intervention.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Pittsburgh

Pittsburgh, Pennsylvania, 15213, United States

Location

Gateway Healthcare

Pawtucket, Rhode Island, 02860, United States

Location

MeSH Terms

Conditions

Anorexia NervosaFeeding and Eating Disorders

Condition Hierarchy (Ancestors)

Mental DisordersSigns and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Andrea B Goldschmidt, Ph.D.

    The University of Pittsburgh

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

December 1, 2021

First Posted

January 11, 2022

Study Start

August 1, 2022

Primary Completion

March 30, 2026

Study Completion

April 30, 2026

Last Updated

April 14, 2026

Record last verified: 2026-04

Data Sharing

IPD Sharing
Will share

Research data from participants will be shared with the broader scientific community through the NIMH Data Archive and the National Database for Clinical Trials related to Mental Illness. Data will be de-identified and harmonized to a common standard. Data will include all adolescent-, caregiver-, and clinician-level variables reflecting eating- and weight-related outcomes, implementation metrics, and treatment mechanisms, and will be accompanied by a data dictionary describing the variables, data structure, and any relevant coding/re-coding schemes. Data will be uploaded at least every six months for the duration of the study. All informed consent/assent documents will include a discussion of how data will be shared with the Data Archive and the research community.

Shared Documents
STUDY PROTOCOL, ANALYTIC CODE
Time Frame
Data will be uploaded at least every 6 months for the duration of the 3-year study.
Access Criteria
We will make data and documentation available only under a data-sharing agreement that provides for (1) a commitment to use the data for research purposes only; (2) a commitment to securing the data using appropriate computer technology; (3) a commitment to destroying or returning the data after analyses are completed; and (4) a commitment not to attempt to identify participants individually.

Locations